Synopsis
Synopsis
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


| Molecular Weight | 398.4 g/mol |
|---|---|
| Molecular Formula | C18H14N4O5S |
| XLogP3 | 2.3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 9 |
| Rotatable Bond Count | 6 |
| Exact Mass | 398.06849073 g/mol |
| Monoisotopic Mass | 398.06849073 g/mol |
| Topological Polar Surface Area | 146 A^2 |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 804 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 6 | |
|---|---|
| Drug Name | Azulfidine |
| PubMed Health | Salicylate (Oral route, Rectal route) |
| Drug Classes | Antirheumatic, Gastrointestinal Agent |
| Drug Label | AZULFIDINE EN-tabs Tablets contain sulfasalazine, formulated in a delayed release tablet (enteric-coated), 500 mg, for oral administration.AZULFIDINE EN-tabs Tablets are film coated with cellulose acetate phthalate to retard disintegration of the tab... |
| Active Ingredient | Sulfasalazine |
| Dosage Form | Tablet; Suspension |
| Route | Oral |
| Strength | 500mg; 250mg/5ml |
| Market Status | Prescription |
| Company | Pharmacia And Upjohn |
| 2 of 6 | |
|---|---|
| Drug Name | Azulfidine en-tabs |
| PubMed Health | Sulfasalazine (By mouth) |
| Drug Label | AZULFIDINE EN-tabs Tablets contain sulfasalazine, formulated in a delayed release tablet (enteric-coated), 500 mg, for oral administration.AZULFIDINE EN-tabs Tablets are film coated with cellulose acetate phthalate to retard disintegration of the tab... |
| Active Ingredient | Sulfasalazine |
| Dosage Form | Tablet; Tablet, delayed release |
| Route | oral; Oral |
| Strength | 500mg |
| Market Status | Prescription |
| Company | Pharmacia Upjohn; Pharmacia And Upjohn |
| 3 of 6 | |
|---|---|
| Drug Name | Sulfasalazine |
| Drug Label | Sulfasalazine Tablets USP, 500 mg for Oral AdministrationTherapeutic classification: Anti-inflammatory agent.Chemical designation: 5-[[p-(2-Pyridylsulfamoyl)phenyl]azo]salicylic acid.Chemical Structure:The molecular weight of sulfasalazine is 398.39.... |
| Active Ingredient | Sulfasalazine |
| Dosage Form | Tablet; Tablet, delayed release |
| Route | Oral |
| Strength | 500mg |
| Market Status | Prescription |
| Company | Vintage Pharms; Watson Labs |
| 4 of 6 | |
|---|---|
| Drug Name | Azulfidine |
| PubMed Health | Salicylate (Oral route, Rectal route) |
| Drug Classes | Antirheumatic, Gastrointestinal Agent |
| Drug Label | AZULFIDINE EN-tabs Tablets contain sulfasalazine, formulated in a delayed release tablet (enteric-coated), 500 mg, for oral administration.AZULFIDINE EN-tabs Tablets are film coated with cellulose acetate phthalate to retard disintegration of the tab... |
| Active Ingredient | Sulfasalazine |
| Dosage Form | Tablet; Suspension |
| Route | Oral |
| Strength | 500mg; 250mg/5ml |
| Market Status | Prescription |
| Company | Pharmacia And Upjohn |
| 5 of 6 | |
|---|---|
| Drug Name | Azulfidine en-tabs |
| PubMed Health | Sulfasalazine (By mouth) |
| Drug Label | AZULFIDINE EN-tabs Tablets contain sulfasalazine, formulated in a delayed release tablet (enteric-coated), 500 mg, for oral administration.AZULFIDINE EN-tabs Tablets are film coated with cellulose acetate phthalate to retard disintegration of the tab... |
| Active Ingredient | Sulfasalazine |
| Dosage Form | Tablet; Tablet, delayed release |
| Route | oral; Oral |
| Strength | 500mg |
| Market Status | Prescription |
| Company | Pharmacia Upjohn; Pharmacia And Upjohn |
| 6 of 6 | |
|---|---|
| Drug Name | Sulfasalazine |
| Drug Label | Sulfasalazine Tablets USP, 500 mg for Oral AdministrationTherapeutic classification: Anti-inflammatory agent.Chemical designation: 5-[[p-(2-Pyridylsulfamoyl)phenyl]azo]salicylic acid.Chemical Structure:The molecular weight of sulfasalazine is 398.39.... |
| Active Ingredient | Sulfasalazine |
| Dosage Form | Tablet; Tablet, delayed release |
| Route | Oral |
| Strength | 500mg |
| Market Status | Prescription |
| Company | Vintage Pharms; Watson Labs |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14688
Submission : 2000-01-17
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 22238
Submission : 2008-11-24
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8886
Submission : 1990-12-10
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14724
Submission : 2000-02-23
Status : Inactive
Type : II
Certificate Number : R1-CEP 2002-088 - Rev 02
Issue Date : 2015-03-20
Type : Chemical
Substance Number : 863
Status : Valid
Registration Number : 306MF10016
Registrant's Address : Waisha Road 99# Jiaojiang Taizhou City, Zhejiang China
Initial Date of Registration : 2024-01-24
Latest Date of Registration :
Registrant Name : Medica Korea Co., Ltd.
Registration Date : 2012-02-24
Registration Number : 20091224-105-F-46-02(1)
Manufacturer Name : Zhejiang Jizhou Pharmaceutical Co., Ltd.
Manufacturer Address : 99 waisha Road, Jiaojiang District, Taizhou City, Zhejiang province, 318000, China

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14751
Submission : 2000-03-08
Status : Inactive
Type : II
Registrant Name : Hanlim Pharmaceutical Co., Ltd.
Registration Date : 2009-12-24
Registration Number : 20091224-105-F-46-02
Manufacturer Name : Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Manufacturer Address : 99 waisha Road, Jiaojiang District, Taizhou City, Zhejiang province, 318000, China

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5145
Submission : 1983-10-18
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7242
Submission : 1987-11-09
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11163
Submission : 1994-10-26
Status : Inactive
Type : II
Certificate Number : R1-CEP 2004-278 - Rev 02
Issue Date : 2017-12-20
Type : Chemical
Substance Number : 863
Status : Withdrawn by Holder

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 6489
Submission : 1986-07-17
Status : Inactive
Type : II

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7242
Submission : 1987-11-09
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5145
Submission : 1983-10-18
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11163
Submission : 1994-10-26
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 16817
Submission : 2003-09-03
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8886
Submission : 1990-12-10
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14688
Submission : 2000-01-17
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17649
Submission : 2004-08-31
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14751
Submission : 2000-03-08
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 14724
Submission : 2000-02-23
Status : Inactive
Type : II

USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7127
Submission : 1987-08-17
Status : Inactive
Type : II

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R1-CEP 1996-040 - Rev 02
Status : Valid
Issue Date : 2007-08-30
Type : Chemical
Substance Number : 863

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R1-CEP 2004-278 - Rev 02
Status : Withdrawn by Holder
Issue Date : 2017-12-20
Type : Chemical
Substance Number : 863

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R1-CEP 2016-225 - Rev 00
Status : Withdrawn by Holder
Issue Date : 2022-01-10
Type : Chemical
Substance Number : 863

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2016-085 - Rev 01
Status : Valid
Issue Date : 2025-06-30
Type : Chemical
Substance Number : 863

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R1-CEP 2002-088 - Rev 02
Status : Valid
Issue Date : 2015-03-20
Type : Chemical
Substance Number : 863

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
CAS Number : 144-83-2
End Use API : Sulfasalazine
About The Company : MENADIONA is an independent privately-owned company, founded in 1970. Ever since, the company has been involved in manufacturing active ingredients (APIs) and k...

CAS Number : 89-57-6
End Use API : Sulfasalazine
About The Company : SMS Lifesciences is a global player in APIs/Intermediates manufacturing having a strong research and manufacturing team supported by state of the art facilities...

CAS Number : 144-83-2
End Use API : Sulfasalazine
About The Company : Zhejiang Jiuzhou Pharmaceutical Co., Ltd. is a medium-scale private enterprise, which focuses in the production of APIs. Our company grows out of Dongshan Chemi...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : SULFASALAZINE
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Approval Date : 1982-01-01
Application Number : 87197
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : SULFASALAZINE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 500MG
Approval Date : 1983-05-24
Application Number : 88052
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : SULFASALAZINE
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Approval Date : 1982-01-01
Application Number : 80197
RX/OTC/DISCN : RX
RLD : No
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : SULFASALAZINE
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Approval Date : 1982-01-01
Application Number : 86184
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : SULFASALAZINE
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Approval Date : 2002-01-11
Application Number : 40349
RX/OTC/DISCN : RX
RLD : No
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code : AB
Brand Name : SULFASALAZINE
Dosage Form : TABLET, DELAYED RELEASE;ORAL
Dosage Strength : 500MG
Approval Date : 2002-01-11
Application Number : 75339
RX/OTC/DISCN : RX
RLD : No
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : Yes
TE Code : AB
Brand Name : AZULFIDINE
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Approval Date : 1982-01-01
Application Number : 7073
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD :
TE Code :
Brand Name : AZULFIDINE EN-TABS
Dosage Form : TABLET; ORAL
Dosage Strength : 500MG
Approval Date :
Application Number : 21243
RX/OTC/DISCN :
RLD :
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : S.A.S.-500
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Approval Date : 1982-01-01
Application Number : 83450
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
RLD : No
TE Code :
Brand Name : SULFASALAZINE
Dosage Form : TABLET;ORAL
Dosage Strength : 500MG
Approval Date : 1987-10-19
Application Number : 89590
RX/OTC/DISCN : DISCN
RLD : No
TE Code :

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
58
PharmaCompass offers a list of Sulfasalazine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Sulfasalazine manufacturer or Sulfasalazine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Sulfasalazine manufacturer or Sulfasalazine supplier.
PharmaCompass also assists you with knowing the Sulfasalazine API Price utilized in the formulation of products. Sulfasalazine API Price is not always fixed or binding as the Sulfasalazine Price is obtained through a variety of data sources. The Sulfasalazine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Saaz-DS manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Saaz-DS, including repackagers and relabelers. The FDA regulates Saaz-DS manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Saaz-DS API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Saaz-DS manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Saaz-DS supplier is an individual or a company that provides Saaz-DS active pharmaceutical ingredient (API) or Saaz-DS finished formulations upon request. The Saaz-DS suppliers may include Saaz-DS API manufacturers, exporters, distributors and traders.
click here to find a list of Saaz-DS suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Saaz-DS DMF (Drug Master File) is a document detailing the whole manufacturing process of Saaz-DS active pharmaceutical ingredient (API) in detail. Different forms of Saaz-DS DMFs exist exist since differing nations have different regulations, such as Saaz-DS USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Saaz-DS DMF submitted to regulatory agencies in the US is known as a USDMF. Saaz-DS USDMF includes data on Saaz-DS's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Saaz-DS USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Saaz-DS suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Saaz-DS Drug Master File in Japan (Saaz-DS JDMF) empowers Saaz-DS API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Saaz-DS JDMF during the approval evaluation for pharmaceutical products. At the time of Saaz-DS JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Saaz-DS suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Saaz-DS Drug Master File in Korea (Saaz-DS KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Saaz-DS. The MFDS reviews the Saaz-DS KDMF as part of the drug registration process and uses the information provided in the Saaz-DS KDMF to evaluate the safety and efficacy of the drug.
After submitting a Saaz-DS KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Saaz-DS API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Saaz-DS suppliers with KDMF on PharmaCompass.
A Saaz-DS CEP of the European Pharmacopoeia monograph is often referred to as a Saaz-DS Certificate of Suitability (COS). The purpose of a Saaz-DS CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Saaz-DS EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Saaz-DS to their clients by showing that a Saaz-DS CEP has been issued for it. The manufacturer submits a Saaz-DS CEP (COS) as part of the market authorization procedure, and it takes on the role of a Saaz-DS CEP holder for the record. Additionally, the data presented in the Saaz-DS CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Saaz-DS DMF.
A Saaz-DS CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Saaz-DS CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Saaz-DS suppliers with CEP (COS) on PharmaCompass.
A Saaz-DS written confirmation (Saaz-DS WC) is an official document issued by a regulatory agency to a Saaz-DS manufacturer, verifying that the manufacturing facility of a Saaz-DS active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Saaz-DS APIs or Saaz-DS finished pharmaceutical products to another nation, regulatory agencies frequently require a Saaz-DS WC (written confirmation) as part of the regulatory process.
click here to find a list of Saaz-DS suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Saaz-DS as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Saaz-DS API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Saaz-DS as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Saaz-DS and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Saaz-DS NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Saaz-DS suppliers with NDC on PharmaCompass.
Saaz-DS Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Saaz-DS GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Saaz-DS GMP manufacturer or Saaz-DS GMP API supplier for your needs.
A Saaz-DS CoA (Certificate of Analysis) is a formal document that attests to Saaz-DS's compliance with Saaz-DS specifications and serves as a tool for batch-level quality control.
Saaz-DS CoA mostly includes findings from lab analyses of a specific batch. For each Saaz-DS CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Saaz-DS may be tested according to a variety of international standards, such as European Pharmacopoeia (Saaz-DS EP), Saaz-DS JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Saaz-DS USP).